Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMVQ3IX)

Drug Name
US9453017, 1 Drug Info
Synonyms CHEMBL3925090; BDBM247409; US9453017, 1
Cross-matching ID
PubChem CID
131635533
TTD Drug ID
DMVQ3IX

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Phospholipase D1 (PLD1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9127005, P2C DMMT98V N. A. N. A. Patented [2]
US9127005, P2B DM3R7BT N. A. N. A. Patented [2]
ML272 DMNEY58 N. A. N. A. Patented [1]
US9127005, P0L DMKLYCV N. A. N. A. Patented [2]
US9453017, 2 DMPH05Y N. A. N. A. Patented [1]
1-(pyridin-2-yl)piperazine DMKE7FG Discovery agent N.A. Investigative [3]
HALOPEMIDE DMF6V8W Discovery agent N.A. Investigative [4]
1-(pyridin-4-yl)piperazine DM78AJ1 Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Phospholipase D1 (PLD1) TT3T17P PLD1_HUMAN Inhibitor [1]

References

1 Antiviral therapies with phospholipase D inhibitors. US9453017.
2 Isoform selective phospholipase D inhibitors. US9127005.
3 Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privil... Bioorg Med Chem Lett. 2009 Apr 15;19(8):2240-3.
4 Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol. 2009 Feb;5(2):108-17.